Two PC12 cell-derived lines have been studied following encapsulation
into polymer-based hollow fibers with respect to secreted catecholamin
es and their metabolites. Cellular encapsulation provides a chronic mi
croperfusion environment within which basally secreted PC12 products c
an be readily measured. Encapsulated PC12 cells grown and held under t
he conditions specified in this report basally release amounts exceedi
ng their total cellular stores of the dopamine precursor L-DOPA and th
e electrochemically active dopamine metabolites DOPAC and HVA during 4
5-min static incubations. Under these same conditions, these cells rel
ease less than 0.1% of their total cellular store of dopamine. Depolar
izing incubations enhance dopamine secretion eightyfold and enhance se
cretion Of L-DOPA, HVA, and DOPAC about twofold. The relative composit
ion of products basally secreted differs between PC12-derived cell lin
es, and an inverse relationship exists between basal release of L-DOPA
and total cellular store of dopamine. These results further indicate
that selected PC12 cell lines are potentially a source of both dopamin
e and L-DOPA in therapeutic cellular replacement applications.